Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Medtronic recalls data management software, urging healthcare providers to run update
The error caused incorrect glucose data to be displayed to clinicians. According to Medtronic, any treatment decisions or recommendations based on those data need to be revisited.
Catheters recalled due to defect—FDA highlights risk of stroke or brain damage
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.
Abbott shares safety concerns with millions of CGM sensors—7 deaths reported
Approximately 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors need to be replaced due to a risk of incorrect glucose readings. Abbott has received reports of 736 severe adverse events and seven deaths that may be related to this issue.
Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs
The timing of this new guidance from the Heart Rhythm Society and American College of Cardiology could not have been better—the document went live just as CMS finalized its decision to cover cardiac ablation procedures performed in ASCs.
Adjustable interatrial shunt for heart failure shows promise in first-in-human trial
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.

Frail patients much more likely to experience major bleeding events following PCI

The new study, published by the American Journal of Cardiology, suggests that frailty could be a helpful predictor for major bleeding events after PCI.

American Indians have an especially high risk of stroke, leaving researchers with many questions

The study included data from nearly 17 million adults who received treatment from 2005 to 2011. Researchers compared the stroke rates of patients with atrial fibrillation and those without it.

TAVR outperforms surgery for low-risk patients after 2 years—but the gap may be shrinking

After two years, TAVR was still linked to a reduction in the study’s primary endpoint, but it was also associated with a greater risk of valve thrombosis.

Healthcare groups from around the world unite to develop a standardized definition of heart failure

Current heart failure definitions are "ambiguous and lack standardization," the groups wrote.

FDA announces recall of Medtronic HVAD pump implant kits after 2 deaths, 19 serious injuries

This is a Class I recall, which means using the device can lead to serious injury or death.

CMS quality initiative will overburden practices ‘still reeling’ from COVID-19, ACR and others warn

Physicians are urging the agency to ease reporting requirements and data collection, according to a letter shared recently.

All radiologists likely to encounter COVID-19 vaccine side effects in coming months, experts say

Massachusetts General Hospital rads outlined steps providers can take to limit unnecessary follow-up care in these situations, sharing their guidance in JACR.

AFib and atrial flutter in the United States: 5 key takeaways from a new analysis

The study, published in the American Journal of Cardiology, shines new light on a significant health issue.

Clinical

Medtronic recalls data management software, urging healthcare providers to run update

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage

Abbott shares safety concerns with millions of CGM sensors—7 deaths reported

Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs

Adjustable interatrial shunt for heart failure shows promise in first-in-human trial